Medicine and Dentistry
Cholangiocarcinoma
100%
Patient
74%
Overall Survival
73%
Surgery
60%
Hepatic Arterial Infusion
54%
Biliary Tract Drainage
36%
Therapeutic Procedure
35%
Inpatient
29%
Floxuridine
26%
Survival
21%
Follow up
18%
Intervention Trial
13%
Systematic Review
12%
Systemic Therapy
9%
Drainage Procedure
9%
Patient Referral
9%
Metastatic Carcinoma
8%
Lesion
8%
Supportive Care
7%
Cancer Registry
7%
Rare Tumor
7%
Diagnosis
7%
Hospital
7%
Cancer Therapy
7%
Neoplasm
5%
Cohort Analysis
5%
Age
5%
Nursing and Health Professions
Patient
99%
Infusion Pump
54%
Bile Duct Carcinoma
43%
Surgery
39%
Chemotherapy
35%
Overall Survival
29%
Survival
9%
Metastasis
8%
Medline
6%
Neoplasm
5%
Cohort Analysis
5%
Man
5%
Woman
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Duct Carcinoma
57%
Infusion Pump
54%
Overall Survival
38%
Floxuridine
26%
Survival
13%
Clinical Trial
9%
Randomized Controlled Trial
9%
Stent
9%
Metastasis
8%
Complication
7%
Neoplasm
5%